Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 350 (RNA5SP350) is a processed pseudogene derived from the 5S ribosomal RNA gene family. Pseudogenes such as RNA5SP350 are considered non-functional remnants of gene duplication or retrotransposition events. Unlike their functional 5S rRNA gene counterparts—which play structural roles in ribosome assembly and function—pseudogenes typically lack regulatory sequences necessary for normal transcription and do not give rise to functional RNA or protein products [2][5]. While a small fraction of pseudogenes have been implicated in molecular regulation (for example, as competitive endogenous RNAs or via antisense effects), most pseudogenes—including RNA5SP350—are not considered biologically active or therapeutically relevant. There is no evidence that RNA5SP350 itself acts as a therapeutic target, biomarker, or disease gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 350 (RNA5SP350).